Advertisement
Advertisement
LPCN
Lipocine Inc.
2.37
USDSponsored
-0.02
-0.84%
May 08, 15:58 UTC -4
Closed
After-Market
2.38
+0.01
+0.63%
LPCN Earnings Reports
Positive Surprise Ratio
LPCN beat 28 of 41 last estimates.
68%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$165.75K
/-$0.44
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
-73.39%
/+7.32%
Lipocine Inc. earnings per share and revenue
On May 06, 2026, LPCN reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.49 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 165.75 thousand, with a --% difference.
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.44 USD, with revenue projected to reach 165.75 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Quoin Pharmaceuticals, Ltd. - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.96
Actual
-$1.77
Surprise
+9.93%
ZOETIS INC.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.63
Actual
$1.53
Surprise
-6.19%
Stevanato Group S.p.A.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.10
Actual
$0.11
Surprise
+5.45%
Crinetics Pharmaceuticals, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.26
Actual
-$1.23
Surprise
+2.51%
NewAmsterdam Pharma Company N.V. Ordinary Shares
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.50
Actual
-$0.40
Surprise
+20.32%
Collegium Pharmaceutical, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$1.62
Actual
$1.76
Surprise
+8.43%
Xeris Biopharma Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+296.08%
Ironwood Pharmaceuticals, Inc. - Class A
Report Date
May 07, 2026 For Q1 26
Estimate
$0.24
Actual
$0.24
Surprise
-1.96%
SIGA Technologies Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
Profound Medical Corp. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+25.75%
FAQ
What were Lipocine Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Lipocine Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Lipocine Inc.'s Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Lipocine Inc. expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Lipocine Inc.'s next earnings report?
Based on 3
analysts, Lipocine Inc. is expected to report EPS of -$0.44 and revenue of $165.75K for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement